Company / Operating Cash Flow per Share
OCULAR THERAPEUTIX, INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.30
FY2025
5-year range
-$1.30 / -$0.70
FY2021-FY2025
Trend
-10.9%
vs FY2024
Sector context
#127 of 212
Health Care
What the data says
At $-1.30, OCULAR THERAPEUTIX, INC's operating cash flow per share ranks #127 of 212 in the Health Care sector. Operating Cash Flow per Share has declined for 3 consecutive years, from $-0.70 in FY2022 to $-1.30 in FY2025.
Based on SEC 10-K filings.
-1.30 in FY2025.
Declined from $-0.91 to $-1.30 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#127 of 212 in Health CareTop 60% of 212This company -$1.30 Sector average $5.28
▼
-124.6% below sector average
Key checks
Key Insights
- OCULAR THERAPEUTIX, INC's operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 10.9% year-over-year.
- Ranks #127 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.30 | -10.9% |
| FY2024 | -$1.17 | -28.8% |
| FY2023 | -$0.91 | -30.3% |
| FY2022 | -$0.70 | +31.6% |
| FY2021 | -$1.02 | +33.8% |
| FY2020 | -$1.54 | -26.8% |
| FY2019 | -$1.22 | +26.8% |
| FY2018 | -$1.66 | +17.7% |
| FY2017 | -$2.02 | -46.8% |
| FY2016 | -$1.37 | -131.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026